|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 7 (April 1), 1999:
pp. 2319-2326
Human Immunodeficiency Virus-Associated Hodgkin's Disease
Derives From Post-Germinal Center B Cells
Antonino Carbone,
Annunziata Gloghini,
Luigi M. Larocca,
Andrea Antinori,
Brunangelo Falini,
Umberto Tirelli,
Riccardo Dalla-Favera, and
Gianluca Gaidano
From the Divisions of Pathology and Medical Oncology and the AIDS
Program, Centro di Riferimento Oncologico, Istituto Nazionale Tumori,
Istituto di Ricovero e Cura a Carattere Scientifico
(IRCCS), Aviano; Institutes of Pathology and Infectious
Diseases, Università Cattolica del Sacro Cuore, Roma; Institute
of Hematology, University of Perugia, Perugia; the Division of Internal
Medicine, the Department of Medical Sciences, Amedeo Avogadro
University of Eastern Piedmont, Novara, Italy; and the Division of
Oncology, the Department of Pathology, College of Physicians and
Surgeons, Columbia University, New York, NY.
Human immunodeficiency virus-associated Hodgkin's disease (HIV-HD)
displays several peculiarities when compared with HD of the general
population. These include overrepresentation of clinically aggressive
histologic types and frequent infection of Reed-Sternberg (RS) cells by
Epstein-Barr virus (EBV). Recently, we have reported that the
histogenesis of HD of the general population may be assessed by
monitoring the expression pattern of BCL-6, a transcription factor
expressed in germinal center (GC) B cells, and of CD138/syndecan-1 (syn-1), a proteoglycan associated with post-GC, terminal B-cell differentiation. In this study, we have applied these two markers to
the study of HIV-HD histogenesis and correlated their expression status
to the virologic features of this disease. We have found that RS cells
of all histologic categories of HIV-HD consistently display the
BCL-6 /syn-1+ phenotype and thus reflect
post-GC B cells. Although BCL-6/syn-1+ RS
cells of HIV-HD express CD40, they are not surrounded by CD40 ligand-positive (CD40L+) reactive T lymphocytes, which,
in HD of the general population, are thought to regulate the disease
phenotype through CD40/CD40L interactions. Conversely, RS cells of
virtually all HIV-HD express the EBV-encoded latent membrane protein 1 (LMP1), which, being functionally homologous to CD40, may contribute,
at least in part, to the modulation of the HIV-HD phenotype.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Carbone, A. Gloghini, and G. Dotti
EBV-Associated Lymphoproliferative Disorders: Classification and Treatment
Oncologist,
May 1, 2008;
13(5):
577 - 585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Attar, S. L. Aquino, and R. P. Hasserjian
Case 33-2007 -- A 49-Year-Old HIV-Positive Man with Anemia
N. Engl. J. Med.,
October 25, 2007;
357(17):
1745 - 1754.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Brauninger, H.-H. Wacker, K. Rajewsky, R. Kuppers, and M.-L. Hansmann
Typing the Histogenetic Origin of the Tumor Cells of Lymphocyte-rich Classical Hodgkin's Lymphoma in Relation to Tumor Cells of Classical and Lymphocyte-predominance Hodgkin's Lymphoma
Cancer Res.,
April 1, 2003;
63(7):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S A Pileri, S Ascani, L Leoncini, E Sabattini, P L Zinzani, P P Piccaluga, A Pileri Jr, M Giunti, B Falini, G B Bolis, et al.
Hodgkin's lymphoma: the pathologist's viewpoint
J. Clin. Pathol.,
March 1, 2002;
55(3):
162 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Teofili, A. L. Di Febo, F. Pierconti, N. Maggiano, M. Bendandi, S. Rutella, A. Cingolani, N. Di Renzo, P. Musto, S. Pileri, et al.
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
Blood,
February 15, 2001;
97(4):
1063 - 1069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Carbone, A. Gloghini, L. M. Larocca, D. Capello, F. Pierconti, V. Canzonieri, U. Tirelli, R. Dalla-Favera, and G. Gaidano
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
Blood,
February 1, 2001;
97(3):
744 - 751.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
